Bionano Genomics在定价1000万美元股票发行后股价下滑

2025-09-16 21:28

Bionano Genomics (NASDAQ:BNGO) has priced a public offering of 5M shares of its common stock (or equivalents) with accompanying Series E and short-term Series F warrants, at a combined public offering price of $2.00 per share and accompanying Series Warrants.
The Series E warrants expire in five years, while the Series F warrants expire in 18 months. Closing is expected on Sept. 17, 2025, pending customary conditions.
The aggregate gross proceeds from the offering are expected to be approximately $10M. The potential additional gross proceeds from the series warrants, if fully exercised on a cash basis, will be approximately $20M. Net proceeds from this offering will be used for working capital and general corporate purposes.
BNGO --42.9% premarket to $1.58
Source: Press Release

More on Bionano Genomics